I challenge you to find a Biotech on the ASX which represents better value than CUV.
ROTFL. Most Companies are listed on the ASX because they can't find anyone to buy their worthless technology. The only thing CUV has actually achieved is getting orphan drug status for a 40 year old drug after 15 years of effort. If you knew anything about the drug approval process you would know orphan drug status isn't hard to obtain.
It seems that most HC 'investors'' actually have absolutely zero formal training or expertise in any of the the technologies they invest in. Many don't even have HSC yet they are self-proclaimed ''experts"' in extremely complex businesses and technologies that probably require a PhD and decades of experience to fully comprehend. They are typically paranoid and accuse of everyone who doesn't have the same starry eyed enthusiasm of being a shorter.
CUV Price at posting:
$28.60 Sentiment: None Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)